Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 2, 2023. (Total: 221654Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Tuberculosis and EGFR[original query]
Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungs.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Feb 7 (2): 299-305.
Luo Yung-Hung, Wu Chieh-Hung, Wu Wen-Shuo, Huang Chu-Yun, Su Wei-Juin, Tsai Chun-Ming, Lee Yu-Chin, Perng Reury-Perng, Chen Yuh-M
Gender-based impact of epidermal growth factor receptor mutation in patients with nonsmall cell lung cancer and previous tuberculosis.
Medicine 2015 Jan 94 (4): e444.
Chang Chia-Hao, Lee Chih-Hsin, Ho Chao-Chi, Wang Jann-Yuan, Yu Chong-J
Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma.
Tuberculosis and respiratory diseases 2018 Jun .
Kim Seo Yun, Myung Jae Kyung, Kim Hye Ryoun, Na Im Il, Koh Jae Soo, Baek Hee Jong, Kim Cheol Hye
Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma.
Cancer research and treatment 2018 Apr .
Hwang In Kyoung, Paik Seung Sook, Lee Seung Hye
Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis.
Tuberculosis and respiratory diseases 2018 Mar .
Paik Seung Sook, Hwang In Kyoung, Park Myung Jae, Lee Seung Hye
Polymorphism in the EREG gene confers susceptibility to tuberculosis.
BMC medical genetics 2019 Jan 20 (1): 7.
Cao Wen, Luo Liu-Lin, Chen Wei-Wei, Liang Li, Zhang Ran-Ran, Zhao Yan-Lin, Chen Jin, Yue J
[Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 4 23 (5): 337-342.
Hu Ying, Yang Xinjie, Nie Lihui, Zhao Dan, An Jun, Li Baol
Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation-Positive Lung Adenocarcinoma.
Tuberculosis and respiratory diseases 2020 Jan 83 (1): 51-60.
Kim Taehee, Cha Yoon Jin, Chang Yoon S
Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor.
Cancer management and research 2021 10 13 7517-7526.
Xie Yalin, Su Ning, Zhou Wei, Lei An, Li Xiang, Li Weiwei, Huang Zhan, Cen Wenchang, Hu Jinxi
The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Adenocarcinoma Referred to a Lung Diseases Hospital; A Cross-Sectional Study from Iran.
Iranian journal of pathology 2022 4 17 (2): 159-165.
Mohammadi Sotoudeh, Rezaei Mitra, Shojaeian Fatemeh, Pourabdollah Mihan, Mohammadi Ziazi Leila, Seifi Sharareh, Doroudinia Atousa, Salimi Babak, Khosravi Adnan, Farhangnasab Mohammad Am
T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma.
Tanaffos 2023 4 21 (3): 376-383.
Mirtavoos-Mahyari Hanifeh, Abbasi Dezfouli Azizollah, Esfahani-Monfared Zahra, Khosravi Adnan, Seifi Sharareh, Sheikhy Kamb
TOP